Astrazeneca 31 (50UC) ニュース

CRWS: Movin'-on-up, to the East Side .... !!!

WNW joined you at .69 not sure why it's still sinking don't see any fresh news...hope it's not a delayed offering

EPIC MOVE COMING!! 🚀🚀🚀🚀🚀🚀

Ignite this e-bike robot lithium battery low floater one more time at .61 cents with a 2m float. Needs some volume then back to $1s

.$MITQ: Moving IMage Tech.: Last of the sub $1.00 "Computer Equipment" sector stocks. Volume & interest rising. Easy tech crowd target. Like the others they will likely will come for $MITQ all at once.
movingimagetech.com/

Scare tactics with zero evidence of a single claim! Same for 3-4 years.
It is impossible to provide evidence of a lost lawsuit because it is a lie!
Honest claims provide FACTS not innuendo. If there were facts you would provide them!
I call you out as a fraud. Prove yourself.

It’s odd that we haven’t heard anything about the new capacity that they are waiting for approval on. Wonder why that it is. If it’s not ready, does this impact launch or would they just work double and triple shifts.

Would help if we for some updates from time to time.

~RDAR .0012

share structure remains the same...

https://investorshub.advfn.com/uimage/uploads/2025/1/15/cbadzRDAR_3.png

Good morning!~Rig

Am I happy with the situation? No Neither am I
Flaskworks systems will be used in the facility. NWBO owns this technology
Sure great, Flaskworks systems will probably also be used in other cancer research and treatment facilities and CDMO's (such as CRL) NWBO will be cooperating with i

I inquired about the timetable of the launch of the Breast cancer test and they answered that all updates are controlled and available at our SEC filings. Just speculating but possibly there is a filing on the way, as I would think they need to partner with a larger Co. The last two words of the em

NEWS -- Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data

https://mma.prnewswire.com/media/1762876/Oncolytics_Biotech_New_Logo.jpg

New pancreatic cancer cohort moves forward w

HQGE must be registered with the SEC (to get any corporate actions approved by the SEC/FINRA) through a Form S-4 (or Form 10) which HQGE can't do because it had its registration with the SEC terminated and still has missing financials from all of 2022, 2023 and the 2024 quarterly report.

Plug Seals Monumental Deal with Allied Green Ammonia for a Mega 3 GW Electrolyzer System

Let's open above 3 bucks today!

https://www.ir.plugpower.com/press-releases/news-details/2025/Plug-Seals-Monumental-Deal-with-Allied-Green-Ammonia-for-a-Mega-3-GW-Electrolyzer-Syste

🔸 $MGNI: Expands partnership with Samsung Ads for programmatic ads in Southeast Asia.

🔸 $S: Downgraded to Neutral from Buy by UBS.

🔸 U.S. Policy: New regulations planned to limit chip exports to China from TSMC, Samsung, and others.

🔸 $CVGW: Q4 EPS 5c vs. -2c last year; revenue up 19.5% to $170M vs. $161.93M est.; adj EBITDA $6.7M.
🔸 $GM: Multi-year deal with Vianode for synthetic graphite for EV batteries.
🔸 $TSLA: SEC sues Elon Musk for late disclosure of Twitter stake in 2022.

Top15 at 7:15
https://ih.advfn.com/markets/nasdaq/premarket

They are already one week late....

$CBDW News - 1606 Corp. Applauds Adnexus Biotechnologies' Launch of Trapicolast: A Revolutionary New AI-Driven Malaria Drug https://finance.yahoo.com/news/1606-corp-applauds-adnexus-biotechnologies-130000493.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

VMAR: THAT would be nice!!

Yes VPN was the answer.

https://investorshub.advfn.com/uimage/uploads/2025/1/15/erpqhxrp_!_14_6m_9pm_DUNCES__RESIST.jpg






https://investorshub.advfn.com/uimage/uploads/2025/1/15/chejpXRP_!_15_CAPT_4am_clonk_resist_cpi_ppi_summary.jpg



This